Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Surgery

β-Blockers—still a trusted ally or time for retirement?

Nature Reviews Cardiology volume 11, pages 502–503 (2014)Cite this article

Subjects

Uncertainty surrounds the benefit of β-blocker treatment in various clinical settings. The researchers in a new retrospective analysis of preoperative β-blocker use in CABG surgery now add to the debate, and suggest that these drugs might not improve perioperative outcomes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Brinkman, W. et al. Preoperative beta-blocker use in coronary artery bypass grafting surgery. JAMA Intern. Med. http://dx.doi.org/10.1001/jamainternmed.2014.2356.

  2. O'Gara, P. T. et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 127, 529–555 (2013).

    Article  Google Scholar 

  3. Society of Thoracic Surgeons. Quality performance measures [online], (2014).

  4. Fleisher, L. A. et al. 2009 ACCF/AHA focused update on perioperative beta blockade incorporated into the ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation 120, e169–e276 (2009).

    PubMed  Google Scholar 

  5. Devereaux, P. J. et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomized controlled trial. Lancet 371, 1839–1847 (2008).

    Article  CAS  Google Scholar 

  6. Bangalore, S. et al. Clinical outcomes with beta-blockers for myocardial infarction: a meta-analysis of randomized trials. Am. J. Med. http://dx.doi.org/10.1016/j.amjmed.2014.05.032.

  7. Chen, Z. M. et al. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 366, 1622–1632 (2005).

    Article  CAS  Google Scholar 

  8. Ferguson, T. B. Jr, Coombs, L. P. & Peterson, E. D. Society of Thoracic Surgeons National Adult Cardiac Surgery Database. Preoperative beta-blocker use and mortality and morbidity following CABG surgery in North America. JAMA 287, 2221–2227 (2002).

    Article  CAS  Google Scholar 

  9. Burgess, D. C., Kilborn, M. J. & Keech, A. C. Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. Eur. Heart J. 27, 2846–2857 (2006).

    Article  Google Scholar 

  10. Shahian, D. M. Preoperative beta-blockade in coronary artery bypass grafting surgery. JAMA Intern. Med. http://dx.doi.org/10.1001/jamainternmed.2014.155.

Download references

Author information

Authors and Affiliations

  1. The Samuel and Jean A. Frankel Cardiovascular Center, Office 2706-SPC 5853, 1500 East Medical Center Drive, Ann Arbor, 48109, Michigan, USA

    Prashant Vaishnava & Kim A. Eagle

Authors
  1. Prashant Vaishnava
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kim A. Eagle
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kim A. Eagle.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vaishnava, P., Eagle, K. β-Blockers—still a trusted ally or time for retirement?. Nat Rev Cardiol 11, 502–503 (2014). https://doi.org/10.1038/nrcardio.2014.112

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2014.112

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing